Skip to main content Accessibility help
×
Home

Gentamicin Treatment Associated with Later Nosocomial Gentamicin-Resistant Serratia marcescens Infections

  • Donald R. Graham (a1), Herbert W. Clegg (a1), Roger L. Anderson (a1), Gladys A. Chelgren (a2), Steven R. Mostow (a2) and Richard E. Dixon (a1)...

Abstract

During a hospital epidemic of infections with gentamicin-resistant Serratia marcescens (GRS), we studied the relation between receiving antibiotics and acquiring GRS. In a five-month period, 22 patients acquired GRS, whereas 18 patients acquired gentamicin-sensitive Serratia (GSS). When compared with patients with nosocomial GSS infection, patients with nosocomial GRS had been in the hospital (p = 0.04) and the intensive care unit (p = 0.003) longer before infection and more had received gentamicin (p = 0.001) or ampicillin (p = 0.02) before infection. To control for the influence of underlying disease, we matched all 12 ICU patients with GRS infection and 12 patients without GRS infection for underlying illness and duration of intensive care. Use of any antibiotic (p = 0.04), or a combination of gentamicin plus ampicillin or cephalosporin (p = 0.047) was more common among patients with GRS infection. The hospital had not significantly increased the use of aminoglycosides from the previous year. We conclude that for the individual patient antimicrobial therapy, especially with gentamicin or ampicillin, creates a risk for later infection by GRS that is independent of the severity of the underlying illness.

Copyright

Corresponding author

Springfield Clinic, 1025 S. 7th St., Springfield, It 62703

References

Hide All
1.Roberts, NJ, Douglas, RG. Gentamicin use and Pseudomonas and Serratia resistance: Effect of a surgical prophylaxis program. Atimicrob Agents Chemother 1978;3:214220.
2.Finland, M. Nosocomial epidemics seriatim. Arch Intern Med 1977;137:585587.
3.Eickhoff, TC. Hospital infections. Disease of the Month. September, 1972.
4.Yu, VL, Oakes, CA, Axnick, KJ, Merigan, TC. Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens. Am J Med 1979;66:468472.
5.Antibiotic resistance and topical treatment. Editorial. Brit Med J 1978;2:649650.
6.Ayliffe, GAJ, Green, W, Livingston, R, Lowbury, EJL. Antibiotic resistant Staphylococcus aureus in dermatology and burn wards. J Clin Pathol 1977:30:4044.
7.Wyatt, TD, Ferguson, WP, Wilson, TS, McCormick, E. Gentamicin resistant Staphylococcus aureus associated with the use of topical gentamicin. J Antimicrob Chemother 1977;3:213217.
8.Lilly, HA, Lowbury, EJL. Antibiotic resistance of Staphylococcus aureus in a burn unit after stopping routine prophylaxis with erythromycin. J Antimicrob Chemother 1978;4:545550.
9.McGowan, JE JrFinland, M. Usage of antibiotics in a general hospital: Effect of requiring justification. J Infect Dis 1974;130:165168.
10.Ruben, FL. Norden, CW, Hruska, E. Factors associated with acquisition of Pseudomonas aeruginosa resistant to gentamicin. Am J Med Sci 1978:275:173179.
11.Buckwold, FJ. Albritton, WL, Ronald, AR, Lertzman, J, Henriksen, R. Investigations of the occurrence of gentamicin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1979;15:152156.
12.Brachman, PS. Epidemiology of nosocomial infections. In: Bennett, JV, Brachman, PS (eds). Hospital Infections. Boston, Little. Brown, 1979:925.
13.Lowbury, EJL, Cason, JS, Jackson, DM, Miller, RWS. Fucidin for staphylococcal infection of burns. Lancet 1962;2:478480.
14.Lowbury, EJL, Babb, JR, Brown, VI, Collins, BJ. Neomycin-resistant Staphylococcus aureus in a burns unit. J Hyg (Camb) 1964;62:221228.
15.Chelgren, GA, LaForce, FM. Limited, periodic surveillance proves practical and effective. Hospitals 1978;52:151154.
16.Edwards, PR, Ewing, WH. Identification of Enterobacteriaceae. 3rd ed. Minneapolis, Burgess Publishing Co. 1972.
17.Bauer, AW, Kirby, WMM, Sherris, JC, Turck, M. Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol 1966;45:493498.
18.Britt, MR. Schleupner, CJ, Matsumiya, S. Severity of underlying disease as a predictor of nosocomial infection. JAMA 1978;239:10471051.
19.Traub, WH. Continued surveillance of Serratia marcescens infections by bacteriocin typing: Investigation of 2 outbreaks of cross-infection in an intensive care unit. Appl Microbiol 1972;23:982985.
20.Grimont, PAD, Grimont, F. Biotyping of Serratia marcescens and its use in epidemiological studies. J Clin Micro 1978;8:7383.
21.Knitile, MA, Eitzman, DV, Baer, H. Role of hand contamination of personnel in the epidemiology of gram-negative nosocomial infection. J Pediatr 1975;86:433437.
22.Selden, R, Lee, S, Wang, WLL, Bennett, JV, Eickhoff, TC. Nosocomial Klebsiella infections. Intestinal colonization as a reservoir. Ann Intern Med 1971;74:657664.
23.Thomas, FE, Jackson, RT, Melly, MA, Alford, RN. Sequential hospitalwide outbreaks of resistant Serratia and Klebsiella infections. Arch Int Med 1977;137:581584.
24.Meyer, RD, Lewis, RP, Halter, J, While, M. Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital. Lancet 1976;1:580583.
25.Center for Disease Control. National Nosocomial Infections Study report, 1977 (6-month summaries), issued November 1979.

Gentamicin Treatment Associated with Later Nosocomial Gentamicin-Resistant Serratia marcescens Infections

  • Donald R. Graham (a1), Herbert W. Clegg (a1), Roger L. Anderson (a1), Gladys A. Chelgren (a2), Steven R. Mostow (a2) and Richard E. Dixon (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.